Resmed Inc at JPMorgan Healthcare Conference Transcript
Good morning, everyone. My name is David Low. I cover healthcare for JP Morgan in Australia. This -- with us this morning is Mick Farrell, CEO of ResMed. I'll hand over to Mick immediately, but we have a breakout in the Yorkshire Room down the corridor as well. Thanks, Mick.
Great. Thanks, David. And welcome, everyone, to day 1 of JP Morgan. This is our forward-looking statements that I will make during the presentation. You can read this on our website, investor.resmed.com.
I wanted to start with our ResMed strategy at the 50,000 feet level and we put a strategy out to 2025 that we presented actually last year here at JP Morgan and we are in play for that for 12 months. I'll give a little bit of an update as to where we are and why our long-term goals still make a lot of sense.
This is -- it's kind of trivializing any type of strategy to put 500, 700 pages of good strategy work into 1 page, but that's the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
